SLC7A11 and osteosarcoma: In conclusion, we reveal that p62 play an important role for SLC7A11 autophagic degradation and our data suggest that SFN exerts its anti-osteosarcoma effects by inducing ferroptosis through targeting p62, leading to the degradation of SLC7A11 via the lysosomal pathway (Fig. 8).